| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |